Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pipa Qingfei granules (also known as Loquat Qingfei Granules) are a traditional Chinese medicine (TCM) compound herbal preparation. It is classed as a category 3.1 innovative TCM based on the ancient classic formula, Pipa Qingfei decoction (Pi Pa Qing Fei Yin), which originates from the Qing-dynasty text *Wài Kē Dà Chéng* (and also recorded in *Yī Zōng Jīn Jiàn*) and is listed in the first Directory of Ancient Classic Formulae of TCM. Developed by Jilin Aodong Taonan Pharmaceutical, the granules clear heat from the lung meridian and are indicated for the treatment of acne vulgaris (specifically acne from wind invading the lung, characterized by red, swollen, painful pimples on the face and nose, thick pus, or dry patches). The formula is composed of six herbs, including loquat leaf (*Folium Eriobotryae*), mulberry bark (*Cortex Mori*), coptis root (*Rhizoma Coptidis* / Huang Lian), amur cork tree bark (*Cortex Phellodendri* / Huang Bai), ginseng (*Radix Ginseng* / Ren Shen), and licorice (*Radix Glycyrrhizae* / Gan Cao).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pipa qingfei granules.